REGN vs UNH · P/E 14, rev $4.29B vs P/E 30, rev $112.03B
Regeneron Pharmaceuticals Inc (REGN) versus UnitedHealth Group Incorporated (UNH) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
UnitedHealth Group Incorporated (UNH) is a healthcare plans company listed on NYSE. It is led by Andrew Witty.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported UNH revenue for 2026-06-30 was $112.03B. Net income was $5.48B. Revenue was up 0.3% from 2026-03-31 to 2026-06-30. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
Not investment advice. Open the REGN and UNH stock pages for the full models.
Not investment advice.